Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States

Autor: Sant, Milena, Allemani, Claudia, De Angelis, Roberta, Carbone, Antonino, De SanJose, Silvia, Gianni, Alessandro M., Giraldo, Pilar, Marchesi, Francesca, Marcos-Gragera, Rafael, Martos-Jimenez, Carmen, Maynadie, Marc, Raphael, Martine, Berrino, Franco, Oberaigner, W., Storm, H. H., Aareleid, T., Jechova, M., Rousarova, M., Hakulinen, T., Hedelin, G., Tron, I., Le Gall, E., Launoy, G., MacE-Lesec'h, J., Faivre, J., Chaplain, G., Carli, P. -. M., Danzon, A., Tretarre, B., Colonna, M., Lacour, B., Raverdy, N., Berger, C., Freycon, F., Grosclaude, P., Estãve, J., Kaatsch, P., Ziegler, H., Holzel, D., Schubert Fritschle, G., Tryggvadottir, L., Berrino, F., Allemani, C., Baili, P., Ciccolallo, L., Crosignani, P., Gatta, G., Micheli, A., Sant, M., Ferretti, S., Contil, E., Ramazzotti, V., Vercelli, M., Quaglia, A., Pannelli, F., Federico, M., Artioli, M. E., Ponz De Leon, M., Benatti, P., De Lisi, V., Servente, L., Zanetti, R., Patriarca, S., Magnani, C., Pastore, G., Gafa, L., Tumino, R., Falcini, F., Budroni, M., Paci, E., Crocetti, E., Zambon, P., Guzzinati, S., Capocaccia, R., Carrani, E., De Angelis, R., Roazzi, P., Santaquilani, M., Tavilla, A., Valente, F., Verdecchia, A., Dalmas, M., Langmark, F., Andersen, A., Rachtan, J., Bielska-Lasota, M., Wronkowski, Z., Plesko, I., Obsitnikova, A., Pompe-Kirn, V., Izarzugaza, I., Martinez-Garcia, C., Garau, I., Navarro, C., Chirlaque, M. D., Ardanaz, E., Moreno, C., Galceran, J., Torrella, A., Peris-Bonet, R., Barlow, L., Moller, T., Jundt, G., Lutz, J. M., Usel, M., Coebergh, J. W. W., Van Der Does-Van Den Berg, A., Visser, O., Godward, S., Coleman, M. P., Williams, E. M. I., Forman, D., Quinn, M. J., Roche, M., Edwards, S., Stiller, C., Verne, J., Mã¸ller, H., Bell, J., Botha, J. L., Lawrence, G., Black, R., Steward, J. A.
Přispěvatelé: Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Istituto Nazionale per lo Studio e la Cura dei Tumori, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Hospital Miguel Servet, Registre des hémopathies malignes de Côte d'Or, Laboratoire d'Hématologie, Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Bicêtre, Department of Preventive & Predictive Medicine, Fondazione IRCCS-Istituto Nazionale dei Tumori, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC ( CEF2P / CARCINO ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Hospital Universitario Miguel Servet, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre, Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (EA 3181) (CEF2P / CARCINO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Oncology
Cancer Research
Survival
Lymphoma
MESH: Registries
MESH : Age Distribution
MESH : Aged
MESH : Child
Preschool
[ SDV.CAN ] Life Sciences [q-bio]/Cancer
0302 clinical medicine
MESH: Aged
80 and over
MESH: Lymphoma
Non-Hodgkin
MESH : Child
MESH: Child
hemic and lymphatic diseases
80 and over
Medicine
Registries
Child
Aged
80 and over
MESH: Aged
MESH: Middle Aged
MESH : Prognosis
Relative survival
Lymphoma
Non-Hodgkin
EUROCARE
Non-Hodgkin's lymphoma
Population cancer registries
US SEER
Adolescent
Adult
Age Distribution
Aged
Child
Preschool
Europe
Feasibility Studies
Humans
Infant
Middle Aged
Prognosis
United States
Absolute risk reduction
MESH : Infant
MESH : Adult
MESH: Infant
3. Good health
030220 oncology & carcinogenesis
morphology - survival - non Hodgkin lymphoma - Europe - US
epidemiology
medicine.medical_specialty
MESH : United States
MESH : Feasibility Studies
MESH : Europe
Socio-culturale
Non-Hodgkin
[SDV.CAN]Life Sciences [q-bio]/Cancer
survival
MESH: Prognosis
cancer
03 medical and health sciences
Internal medicine
MESH : Adolescent
MESH: United States
MESH : Lymphoma
Non-Hodgkin
MESH : Middle Aged
Preschool
MESH : Aged
80 and over
MESH: Age Distribution
MESH: Adolescent
MESH: Humans
business.industry
MESH: Child
Preschool
MESH : Humans
Cancer
MESH: Adult
medicine.disease
Confidence interval
Cancer registry
Hodgkin lymphoma
MESH: Europe
business
MESH: Feasibility Studies
MESH : Registries
030215 immunology
Zdroj: European Journal of Cancer
European Journal of Cancer, Elsevier, 2008, 44 (4), pp.579-587. 〈10.1016/j.ejca.2007.12.016〉
European Journal of Cancer, Elsevier, 2008, 44 (4), pp.579-587. ⟨10.1016/j.ejca.2007.12.016⟩
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2007.12.016〉
Popis: International audience; We explored the influence of morphology on geographic differences in 5-year survival for non-Hodgkin lymphoma (NHL) diagnosed in 1990-1994 and followed for 5years: 16,955 cases from 27 EUROCARE-3 cancer registries, and 22,713 cases from 9 US SEER registries. Overall 5-year relative survival was 56.1% in EUROCARE west, 47.1% in EUROCARE east and 56.3% in SEER. Relative excess risk (RER) of death was 1.05 (95% confidence interval (CI) 1.01-1.10) in EUROCARE west, 1.52 (95% CI 1.44-1.60) in EUROCARE east (SEER reference). Excess risk of death was significantly above reference (diffuse B lymphoma) for Burkitt's and NOS lymphoma; not different for lymphoblastic and other T-cell; significantly below reference (in the order of decreasing relative excess risk) for NHL NOS, mantle cell/centrocytic, lymphoplasmacytic, follicular, small lymphocytic/chronic lymphocytic leukaemia, other specified NHL and cutaneous morphologies. Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved.
Databáze: OpenAIRE
Externí odkaz: